Does lapatinib, a small-molecule tyrosine kinase inhibitor,...

Does lapatinib, a small-molecule tyrosine kinase inhibitor, constitute a breakthrough in the treatment of breast cancer?

Yoshinori Ito, Nahomi Tokudome, Tsutomu Sugihara, Shunji Takahashi, Kiyohiko Hatake
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Pages:
7
DOI:
10.2325/jbcs.971
Date:
April, 2007
File:
PDF, 697 KB
english, 2007
Conversion to is in progress
Conversion to is failed